Document:

Filed by OTC Filings Inc. - www.otcedgar.com - 1-866-832-FILE (3453) - Pharma Investing News, Inc. -Exhibit 10.1

  
 
 CONTROL SHAREHOLDER AGREEMENT
  
  
 THIS CONTROL SHAREHOLDER AGREEMENT(this “Agreement”) made effective as of the 13th day of December 2013 (the “Effective Date”),
 
 BETWEEN:

 Pharma Investing News, Inc. ("PINV" or the "Corporation"), a Nevada corporationwith its corporate offices located at 9107 Wilshire Blvd., Suite 450, Beverly Hills, CA 90210.
 
OF THE FIRST PART
 
- and –
  
 Castor Management Services, Inc., 9107 Wilshire Blvd Suite 450, Beverly Hills, CA 90210 (with president of Mark Jordan of California, USA) or its Assigns (“Castor”)
  
 - and –
  
 BHD Holding B.V. with registered address Hemonystraat 11, 1074 BK Amsterdam, The Netherlands (owned by Dorothy H. Bray, Ph.D. of the UK) or its Assigns (“BHD”)
  
 - and –
 
Khadija Benlhassan-Chahour, Ph.D. with address of 13 Avenue des Vosges, 77270 Villeparisis, Paris, France, or her Assigns (“KBC”)
  
 - and –
  
 CSJ Group LLC with address of 1754 Willard Street NW #3, Washington, DC, USA (owned by Chad S. Johnson, Esq., of Washington, DC, USA), or its Assigns (“CSJ”)
  
 Castor, BHD, KBC and CSJ are hereinafter referred to as the “Control Shareholders” or individually a "Control Shareholder" of PINV.  Hereinafter the Control Shareholders and PINV are referred to as the "Parties" or individually as a "Party".
 
OF THE SECOND PART

WHEREAS: 

A. Control Shareholders will provide Control services ("Control Services") to the Corporation in an executive capacity;

B. Control Shareholders hold shares directly or indirectly in the Corporation.

  	                  

	              

 C. The Control Shareholders desire to assure stable governance of the Corporation through the Control Services of the Control Shareholders for an indefinite term and the Parties are entering into this Agreement for that purpose and in order to set forth the terms of the Agreement.
  
 D.  Castor and BHD, so long as both are Parties to the Agreement, are intended by this Agreement to maintain equal control (50% / 50%) over voting matters of the Corporation, as if Castor's and BHD's cumulative two votes were a unanimous vote of all controlling shares.

 NOW THEREFORE, in consideration of the foregoing and of the mutual covenants contained herein, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:
 
1.        Term of Control Services.
  
 The Corporation hereby requests the Services of the Control Shareholders until this Agreement is terminated by any clause in this Agreement ("Control Term").

2.        Duties of Control Shareholders.
  
 2.1.      The Control Shareholders shall do and perform all services, acts and things necessary or advisable consistent with law in that capacity in connection with the conduct of the business of the Corporation.

  
 2.2.      The Control Shareholders shall devote adequate services to accommodate the business of the Corporation during the Control Term. A Control Shareholder may devote time and effort to personal activities to the extent that such activities do not materially interfere with the performance of his or her duties hereunder. If the Corporation advises the Control Shareholder that, in its good faith judgment, such activities are materially interfering with the performance of the Control Shareholder's duties hereunder, the Control Shareholder will promptly take steps to rectify the issue.
  
 3.         Compensation of Control Shareholders.
  
 3.1.      Compensation for the services hereunder, effective the First (1st) of January 2014, each Control Shareholder or its assigns shall be entitled to receive a per diem ("Compensation") of not more than twelve thousand US dollars ($12,000.00) per year, payable in installments on the Corporation's regular payroll dates or such other dates as the Parties may reasonably determine from time to time.  In the occurrence that all Control Shareholders deem the funds unavailable, the Compensation shall be accrued and paid out on a latter date within a reasonable time in the form of additional shares of the Corporation or cash payment at the mutually agreed discretion of all the Control Shareholders.
  	                  

	              

 The Corporation's Board of Directors will review the compensation annually, and, with the approval of all the Control Shareholders, may (but shall be under no obligation to) further increase such Compensation. 
  
 3.2.       Expenses associated with the Corporation’s normal business shall be reasonable and approved by the Board of Directors before payment or reimbursement. Payment or reimbursement shall be given priority over the Compensation and be provided immediately or as soon thereafter as possible after submission of the expense reports and approval in a manner determined by the Board of Directors.
  
 4.          Compensation from Share Pooling Arrangement.
  
 4.1.       The Control Shareholders all agree to place all, meaning one million (1,000,000) series A preferred shares of the Corporation (the "Control Shares") under the beneficial control of the Control Shareholders in pool with an Escrow Agent initially to be appointed by mutual decision of Castor and BHD.  A list of each Control Shareholder's Control Shares is attached as Schedule “A”.
  
4.2.       The Escrow Agent will release the Control Shares from escrow with the written consent of all of the Control Shareholders.  The Escrow Agent will place the Control Shares into an appropriate account pending further instructions by the written consent of all of the Control Shareholders.
  
 5.         Compensation to others.
  
 The Control Shareholders shall agree before any issuance of incentive shares are provided to other parties for their services as directors, officers, new, and/or any other positions deemed necessary and appropriate for the furtherance of the business of the Corporation.
  
 6.         Voting of Shares in Escrow.
  
 The Control Shareholders will receive a Proxy of Voting Rights to all Control Shares in pool with the Escrow Agent.  The written consent of each of Castor and BHDshall agree for all voting decisions including but not limited to all new common share issuances, so long as each of Castor and BHD (or their assigns) are Control Shareholders.  If one or both of Castor and of BHD (inclusive of their assigns) are no longer Control Shareholders, the agreement of all Control Shareholders will be required for all voting decisions including but not limited to all new share issuances.
  
  	                  

	              

 7.         Covenants.
  
 7.1       Disclosure of Information.  During the term of this Agreement and thereafter, each Party shall not, at any time, directly or indirectly, disclose any confidential or proprietary information for any reason or purpose whatsoever to any person, firm, corporation, association or other entity to legal and financial advisors who agree in writing to maintain the confidentiality of such confidential or proprietary information on terms substantially similar to those stated here, nor shall either Party directly or indirectly make use of any such confidential or proprietary information for its own purpose or for the benefit of any person, firm, corporation, association or other entity except as provided and contemplated herein, and each Party hereby acknowledges that each Party or affiliates would be irreparably damaged if such confidential or proprietary information were disclosed to or utilized on behalf of others in competition in any respect with the other Party or any affiliate thereof.  For the purposes of this Section 7, the term "confidential or proprietary information" shall mean all information concerning the business, customers or affairs of either Party or any affiliate thereof, including matters such as trade secrets, research and development activities, books and records, customer lists, suppliers, distribution channels, pricing information, private processes, software, functional specifications, blueprints, know-how, data, improvements, discoveries, designs, inventions, techniques, marketing plans, strategies, forecasts, new products and financial statements as they may exist from time to time, which the other Party may have acquired or obtained by virtue of its relationship with each other or any subsidiary or affiliate thereof, except for such information which (i) becomes generally available to the public, other than as the result of a disclosure made directly or indirectly by a Party, (ii) was known to the person, firm, corporation or other entity to which such information was disclosed by a Party prior to its disclosure directly or indirectly by the other Party, (iii) was previously available to the person, firm, corporation or other entity to which such information was disclosed directly or indirectly by a Party on a non-confidential basis from a source which was entitled to disclose the same or (iv) if required by law, governmental order or decree to be disclosed by a Party.
  
 7.2        Injunctive Relief.  Each Party hereto acknowledges that the provisions of this Section 7 are reasonable and necessary for the protection of each Party’s interests and that a Party will be irrevocably damaged if such covenants are not specifically enforced.  Accordingly, each Party hereto agrees that, in addition to any other relief to which the another Party or Parties may be entitled in the form of actual or punitive damages, the another Party or Parties shall be entitled to seek and obtain injunctive relief from a court of competent jurisdiction for the purposes of restraining the offending Party from any actual or threatened breach of such covenants.
  
 8.          Applicable Governing Law.  
  
 This Agreement shall be exclusively governed by and construed in accordance with the laws of the State of Nevada, USA.
  
 9.         Notices.  
  
 Any notice or other communication under this Agreement shall be in writing and shall be considered given when delivered personally or three business days after mailing by U.S., U.K., Canadian, Dutch, French or other relevant governmental registered mail, return receipt requested, to the Parties at their respective addresses or at such other address as a Party may specify by notice to the others.  
 

  	                  

	              

  
 10.        Entire Agreement; Amendment.  
                                                                     
 This Agreement shall supersede all existing agreements between the Control Shareholders relating to the terms of this Agreement. This Agreement may not be amended except by written agreement of both of Castor and of BHD (or their assigns), signed by both parties so long as both are Parties to this Agreement.  If one or both of Castor and of BHD (inclusive of their assigns) are no longer Control Shareholders, the written consent of all Control Shareholders will be required for any amendment to this Agreement.
  
 11.        Waiver.  
  
 The failure of a Party to insist upon strict adherence to any term of this Agreement on any occasion shall not be considered a waiver thereof or deprive that Party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement.
  
 12.         Sale, Assignment, or Other Disposition and Right of First Refusal.
  
 In case Castor or BHD intends to sell or assign all or part of its Control Shares to a third party excluding immediate family member(s), written notice must be provided to the other party and such other party shall have 90 days right of first refusal to purchase such shares at a price determined by an ASA-accredited independent valuation appraiser, such party may waive such valuation in writing to facilitate the sale and assignment at an earlier date.  Only with the approval of both Castor and BHD, each of the other original Control Shareholders may sell or assign all or part of its Control Shares to a third party to purchase such shares through the same valuation process described in this paragraph, subject to the right of first refusal of Castor and BHD.
  
 13.         Headings.  
  
 The section headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.
  
 14.        Counterparts and Facsimile Signature.  
  
 This Agreement may be signed in counterparts, all of which when taken together shall constitute a single executed document and signatures transmitted by facsimile or generally accepted electronic means shall be deemed valid execution of this Agreement binding on the Parties.
  
 15.        Authority.  
   
 Each Party represents and warrants to the other that the signature below by each Party’s agent or representative is duly authorized by each Party’s governing body and governing documents, and that each signature is duly effective to bind such Party to this Agreement in accordance with its terms.
  
 16.        Indemnity.
  
  	                  

	              

 Each Party shall indemnify, defend and hold harmless each other, its directors, officers and shareholders from and against any and all demands, claims actions or causes of action, assessments, losses, damages, liabilities, costs, and expenses, including, without limitation, reasonable attorney’s fees and related costs, asserted against, relating to, imposed upon, or incurred by a Party, directly or indirectly, by reason of, resulting from, or arising in connection with a Party's operations during the term of this Agreement.
  
 17.        Termination.
  
 Should this Agreement become terminated, the Control Shares issued to each of the aforementioned Control Shareholders shall be retained and distributed to each Control Shareholder in the spirit of the Agreement.
  
 

[Signature Page to Follow]
  
 

  	                  

	              

 IN WITNESS WHEREOF, the undersigned Parties have executed this Agreement as of the date first written above.
  
             /s/ Mark Jordan                                                            /s/ Dorothy H. Bray
             __________________                                                ____________________                   
            Castor Management Services, Inc.                                BHD Holding BV
 by Mark Jordan, President                                            by Dorothy H. Bray, Ph.D., Owner
  
             /s/ Khadija Benlhassan-Chahour                                 /s/ Chad S. Johnson
 ___________________                                              ___________________
             Khadija Benlhassan-Chahour, Ph.D.                             CSJ Group LLC 
                                                                                                 by Chad S. Johnson, Esq., Owner
  
             /s/ Chad S. Johnson
             ___________________
             Pharma Investing News, Inc.
             by Chad S. Johnson, Esq., Director
  
  
  
 [Schedule A to Follow]
 
 
  
  
  	                 

	              

 Schedule A
 
Control Shareholders' List and Respective Number of Control Shares
  
  
  	 Name of Shareholder
	 Number of Shares

	  
 Castor Management Services, Inc.
  
	  
 500,000

	  
 BHD Holding BV
  
	  
 370,000

	  
 Khadija Benlhassan-Chahour, Ph.D.
  
	  
 100,000

	  
 CSJ Group LLC
	  
 30,000Filed by OTC Filings Inc. - www.otcedgar.com - 1-866-832-FILE (3453) - Pharma Investing News, Inc. -Exhibit 10.2

  
 
  
 
 EXECUTIVE MANAGEMENT AND BONUS AGREEMENT
 
 
 THIS AGREEMENT (the "Agreement") effective as of this thirteenth (13th) day of December 2013 (the “Effective Date”), entered into between Pharma Investing News, Inc. a Nevada Corporation, with its principal offices located at 9107 Wilshire Blvd, Suite 450, Beverly Hills, CA 90210 (the “Company” or “PINV”) and Dr. Dorothy H Bray of the United Kingdom (the “Executive”) (together, the Company and the Executive may be referred to herein as the "parties", or each individually as a "party").
  
 WHEREAS:
  
 A.      The Company is in the business of developing patented technology devices and systems for manufacturing, marketing, and distribution worldwide and developing patented and/or protected pharmaceutical, medicinal, food, nutrition, and other products for worldwide marketing and distribution;
  
 B.      The Company wishes to engage the services of the Executive as an executive of the Company; and
  
 C.      The Company and the Executive have agreed to enter into an executive management agreement for their mutual benefit.
  
 THIS AGREEMENT WITNESSES THAT in consideration of the premises and mutual covenants contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties, intending to be legally bound hereby, agree as follows:
  
 1.        ENGAGEMENT AS AN EXECUTIVE
  
 1.1       The Company hereby engages the Executive as an executive of the Company, to undertake the duties and title of Member, Board of Directors, and to undertake the duties and title of Chief Executive Officer & President, and the Executive agrees to exercise those powers as requested by the Company or its subsidiaries from time to time, (collectively the “Services”) and the Executive accepts such engagement on the terms and conditions set forth in this Agreement.
  
 2.        TERM OF THIS AGREEMENT
  
 2.1       The term of this Agreement shall begin as of the Effective Date and shall continue for five (5) years or until terminated earlier pursuant to Sections 10 and 11 herein (the “Term”).  Any renewal period for this Agreement shall be at the sole discretion of the Company including any compensation or stock/stock option compensation for services paid to the Executive during the renewal term.
  
 3.        EXECUTIVE SERVICES
  
 3.1       The Executive shall undertake and perform the duties and responsibilities commonly associated with acting in the capacities of Director and Chief Executive Officer (CEO) & President.  The Executive agrees that Executive's duties may be reasonably modified by written agreement of both the Company and the Executive from time to time.
  
 3.2        In providing the Services the Executive shall:
  
 ·        comply with all applicable local statutes, laws and regulations;
 ·        not make any misrepresentation or omit to state any material fact which results in a misrepresentation regarding the business of the Company; 
 ·        not disclose, release or publish any information regarding the Company without the prior written consent of the Company; and
 not employ any person in any capacity, or contract for the purchase or rental of any service, article or material, nor make any commitment, agreement or obligation whereby the Company shall be required to pay any monies or other consideration without the Company's prior written consent. 

  	                 

	              

 4.        EXECUTIVE COMPENSATION
  
 4.1      Management Fees.  As compensation for services provided for the executive roles in the Company, the Company shall pay the Executive or Executive's assigns $10,000 per month for the first three months (December 2013, January 2014, and February 2014) and $23,333 per month for the nine months thereafter (March through November 2014) through to the end of the first year of service under this Agreement, considered to be November 30, 2014.  (The first month shall be considered the remainder of December 2013 and the fee paid for this first month shall not be fractionalized.)  In subsequent years of service, the monthly fee shall be determined by a majority vote of the shareholders of the Company, following a recommendation from the Company's Board of Directors.  Notwithstanding the provisions regarding evaluation for bonuses and fee increases contained herein, it is agreed that the monthly fee paid to the Executiveor Executive'sassigns shall be reevaluated for increase as of June 1, 2014 and annually.  All Management Fee payments shall be paid to the Executive or Executive's assigns semi-monthly on the 15th and last day of each calendar month, or prior business day if any of those days fall on a week or statutory holiday.
  
 4.2       Bonus Shares.  As a signing bonus for acting as CEO & President and Director of the Company, the Company shall, within seven (7) days of the Executive's signing of this Agreement, or as soon as possible to this time frame, pay the Executive one million (1,000,000) Form S-8 registered free-trading common shares of the Company common stock and pay to the Executive or Executive's assigns one million (1,000,000) Rule 144 restricted common shares of the Company common stock, followed by payments one year following the signing of the Agreement (considered November 30, 2014) of an identical stock bonus to the Executive of an additional one million (1,000,000) Form S-8 registered free-trading common shares of the Company common stock and to the Executive or Executive's assigns one million (1,000,000) Rule 144 restricted common shares of the Company common stock.  All bonus shares are considered fully earned on signing and issuance.  The Company’s common stock, par value $0.001 per share, currently trades on the NASDAQ OTC Bulletin Board under the symbol ‘PINV’.  The proceeds from the sale of S-8 shares shall be for services to the Company as determined by the Board of Directors.
  
 4.3       Performance Bonus.As further compensation based on job and Company performance, product development, new patents, branding, product sales, achievement of project or operational milestones, the Company is committed to providing additional cash and stock bonuses to the Executive or Executive's assigns, typically to be considered at least annually. Such bonuses will be at the sole discretion of the Company based on overall performance and available operating cash flow.  The Company reserves the right to issue equivalent after-tax value in free-trading common stock in lieu of cash bonuses.
  
 4.4       Additional Compensation Provisions.  Hereinafter, Sections 4.1 through 4.4 are collectively referred to as the “Compensation”.  The Compensation shall not be adversely affected by any change of title with or corporate duties within the Company, so long as Services continue to be provided to the Company, as it is expected that positions within the Company may evolve over time.  
  
 	                 

	              

  
5.        REIMBURSEMENT OF EXPENSES
  
 5.1       The parties agree that the Compensation hereunder is not inclusive of any and all fees or expenses incurred by the Executive on the Company’s behalf pursuant to this Agreement including the costs of rendering the Services.  It is expected that the Company will provide the Executive a computer and software allowance in the first month or a reimbursement for this purpose.  The Companyshall reimburse the Executive for any bona fide expenses including but not limited to travel and telephone incurred by the Executive on behalf of the Company in connection with the provision of the Services upon the Executive submitting to the Company an itemized written account of such expenses and corresponding expense receipts in a form acceptable to the Company within 20 days after the Executive incurs such expenses or within a time period agreed to by the Parties.  
  
 6.        CONFIDENTIALITY
  
 6.1       The Executive shall not disclose to any third party without the prior consent of the Company any financial or business information concerning the business, affairs, plans and programs of the Company its directors, officers, shareholders, employees, or consultants (the "Confidential Information").  The Executive shall not be bound by the foregoing limitation in the event (i) the Confidential Information is otherwise disseminated and becomes public information or (ii) the Executive is required to disclose the Confidential Informational pursuant to a subpoena or other judicial order.  As a material inducement to the Company entering into this Agreement, the Executive shall, at the Company’s request, execute a confidentiality and non-disclosure agreement in a form mutually agreed upon by the Company and the Executive.
  
 7.        GRANTS OF RIGHTS AND INSURANCE
  
 7.1       The Executive agrees that the results and proceeds of the Services under this Agreement, although not created in an employment relationship, shall, for the purpose of copyright only, be deemed a work made in the course of employment under United Kingdom, France, Netherlands, or Canadian law or a work-made-for-hire under the United States law and all other comparable international intellectual property laws and conventions.  All intellectual property rights and any other rights which the Executive may have in and to any work, materials, or other results and proceeds of the Services hereunder shall vest irrevocably and exclusively with the Company and are otherwise hereby assigned to the Company as and when created.  The Executive hereby waives any moral rights of authors or similar rights the Executive may have in or to the results and proceeds of the Executive Services hereunder.
  
 7.3       The Company shall have the right to apply for and take out, at the Company's expense, life, health, accident, or other insurance covering the Executive, in any amount the Company deems necessary to protect the Company's interest hereunder with prior notice given to the Executive.  The Executive shall not have any right, title, or interest in or to such insurance.
  
 8.        REPRESENTATIONS AND WARRANTIES
  
 8.1       The Executive represents, warrants and covenants to the Company as follows: 
  
 (a)    the Executive is not under any contractual or other restriction which is inconsistent with the execution of this Agreement, the performance of the Services hereunder or any other rights of the Company hereunder;
  
 (b)   the Executive is not under any physical or mental disability that would hinder the performance of Executive's duties under this Agreement; and
  
 (c)    the Company will provide and disclose all legal and commercial information to the Executive that is necessary to perform Executive’s duties.
  
 	                 

	               

  
9.        INDEMNIFICATION
  
 9.1       The Executive shall indemnify and hold harmless the Company, its partners, financiers, parent, affiliated and related companies, and all of their respective individual shareholders, directors, officers, employees, licensees and assigns from and against any claims, actions, losses and expenses (including legal expenses) occasioned by any breach by the Executive of any representations and warranties contained in, or by any breach of any other provision of, this Agreement by the Executive.
  
 9.2       The Company shall indemnify and hold harmless the Executive, its partners, financiers, parent, affiliated and related companies, and all of their respective individual shareholders, directors, officers, employees, licensees and assigns from and against any claims, actions, losses and expenses (including legal expenses) occasioned by any breach by the Company of any representations and warranties contained in, or by any breach of any other provision of, this Agreement by the Company.
  
 10.        NO OBLIGATION TO PROCEED.  
  
 10.1       Nothing herein contained shall in any way obligate the Company to use the Services hereunder or to exploit the results and proceeds of the Services hereunder; provided that, upon the condition that the Executive is not in material default of the terms and conditions hereof, nothing contained in this section 10.1 shall relieve the Company of its obligation to deliver to the Executive the Compensation.  All of the foregoing shall be subject to the other terms and conditions of this Agreement (including, without limitation, the Company’s right of termination, disability and default).
  
 11.        RIGHT OF TERMINATION.  
  
 11.1       The Company and the Executive shall each have the right to terminate this Agreement at any time in its sole discretion by giving not less than 90 days written notice. All Compensation due to the Executive must be paid in full prior to any termination taking effect upon which all monies due to the Executive will be considered paid in full for the term the services were performed. Upon termination of this Agreement the Executive shall continue to work with the Company to fulfill the obligations of this Agreement during the notice period and this period will be paid for per terms of this Agreement.  All stock bonuses and stock and options vested at the time of termination shall remain under the ownership of the Executive and shall remain exercisable until expiry.
  
 12.        DEFAULT/DISABILITY. 
  
 12.1      No act or omission of the Company hereunder shall constitute an event of default or breach of this Agreement unless the Executive shall first notify the Company in writing setting forth such alleged breach or default and the Company shall cure said alleged breach or default within 10 days after receipt of such notice (or commence said cure within said ten days if the matter cannot be cured in ten days, and shall diligently continue to complete said cure).  Upon any material breach or de­fault by the Executive of any of the terms and conditions hereof, or the terms and conditions of any other agreement between the Company and the Executive for the services of the Executive, the Executive may cure said alleged breach or default within 10 days after receipt of such notice (or commence said cure within said ten days if the matter cannot be cured in ten days, and shall diligently continue to complete said cure), or the Company shall immediately have the right to suspend or to terminate this Agreement and any other agreement between the Company and the Executive for the services of the Executive.  
 

 
  	                 

	              

 13.        COMPANY'S REMEDIES.  
  
 13.1       The services to be rendered by the Executive hereunder and the rights and privileges herein granted to the Company are of a special, unique, unusual, extraordinary and intellectual character which gives them a peculiar value, the loss of which cannot be reasonably or adequately compensated in damages in an action at law, it being understood and agreed that a breach by the Executive of any of the provisions of this Agreement shall cause the Company irreparable injury and damages.  The Executive expressly agrees that the Company shall be entitled to seek injunctive and/or other equitable relief to prevent a breach hereof by the Executive.  Resort to such equitable relief, however, shall not be construed as a waiver of any other rights or remedies which the Company may have in the premises for damages or otherwise.
  
 14.       RELATIONSHIP.  
  
 14.1      Nothing herein shall be construed as creating a partnership, joint venture, or master-servant relationship between the parties for any purpose whatsoever.  Except as may be expressly provided herein, neither party may be held responsible for the acts either of omission or commission of the other party, and neither party is authorized, or has the power, to obligate or bind the other party by contract, agreement, warranty, representation or otherwise in any manner. 
  
 15.      MISCELLANEOUS PROVISIONS
  
 (a)    Time.  Time is of the essence of this Agreement.
  
 (b)   Presumption.  This Agreement or any section thereof shall not be construed against any party due to the fact that said Agreement or any section thereof was drafted by said party.
  
 (c)    Titles and Captions.  All article, section and paragraph titles or captions contained in this Agreement are for convenience only and shall not be deemed part of the context nor affect the interpretation of this Agreement.
  
 (d)   Further Action.  The parties hereto shall execute and deliver all documents, provide all information and take or forbear from all such action as may be necessary or appropriate to achieve the purposes of this Agreement.
  
 (e)    Savings Clause.  If any provision of this Agreement, or the application of such provision to any person or circumstance, shall be held invalid, the remainder of this Agreement, or the application of such provision to persons or circumstances other than those as to which it is held invalid, shall not be affected thereby.
  
 (f)     Assignment.  The Company may assign this Agreement, in whole or in part, at any time to any party, as the Company shall determine in its sole discretion; pro­vided that, no such assignment shall relieve the Company of its obligations hereunder unless consented to by the Executive in writing.  The Executive may assign this Agreement with the prior consent of the Company, which consent shall not be unreasonably withheld.
  
  	                 

	              

 (g)     Notices.  All notices required, or permitted to be given, under this Agreement shall be given in writing and shall be delivered, either personally or by express delivery service, to the party to be notified.  Notice to each party shall be deemed to have been duly given upon delivery, personally or by courier, addressed to the attention of the officer at the address set forth heretofore, or to such other officer or addresses as either party may designate, upon at least ten   (10) days written notice, to the other party. 
  
 (h)   Entire Agreement.  This Agreement contains the entire understanding and agreement among the parties.  There are no other agreements, conditions or representations, oral or written, express or implied, with regard thereto.  This Agreement may be amended only in writing signed by all parties.
  
 (i)    Waiver.  A delay or failure by any party to exercise a right under this Agreement, or a partial or single exercise of that right, shall not constitute a waiver of that or any other right.
  
 (j)   Counterparts.  This Agreement may be executed in duplicate counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same Agreement.   Counterparts delivered by electronic means and/or which contain electronic signatures shall be permitted and form valid counterparts or validly executed counterparts, respectively.
  
 (k)    Successors.  The provisions of this Agreement shall be binding upon all parties, their successors and permitted assigns. 
  
 (l)     Counsel.  The parties expressly acknowledge that each has been advised to seek separate counsel for advice in this matter and has been given a reasonable opportunity to do so.
  
 [Signature Page Follows]
  
 
  	                 

	              

  
IN WITNESS WHEREOF, the parties have duly executed and delivered this Agreement as of the date first written above.
  
 PHARMA INVESTING NEWS, INC.                                                         
  
 Per:  /s/ Chad S. Johnson
 ________________________________
 Chad S. Johnson, Esq.
 Director, President & CEO                                            
  
  
  
 EXECUTIVE:
  
 Per: /s/ Dr. Dorothy Helen Bray
 _______________________________
 Dr. Dorothy Helen Bray

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00224-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00224-of-00352.parquet"}]]